Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Biofrontera AG
  6. News
  7. Summary
    B8F   DE0006046113

BIOFRONTERA AG

(B8F)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Lower in Friday Trading

09/24/2021 | 11:21am EDT


© MT Newswires 2021
All news about BIOFRONTERA AG
10/15European ADRs Move Higher in Friday Trading
MT
10/11European ADRs Move Higher in Monday Trading
MT
10/01BIOFRONTERA : reports preliminary approximate revenues for the month of September 2021 (Fo..
PU
10/01BIOFRONTERA : Leverkusen, Germany, October 1, 2021 – Biofrontera AG currently holds ..
PU
10/01PTA-NEWS : Biofrontera AG: Biofrontera reports preliminary approximate revenues for the mo..
PU
10/01Biofrontera reports preliminary approximate revenues for the month of September 2021
GL
10/01BIOFRONTERA : reports preliminary approximate revenues for the month of September 2021
GL
10/01Biofrontera Reports Preliminary Revenue Results for the Month and Year to Date Ended Se..
CI
09/29European ADRs Move Higher in Wednesday Trading
MT
09/24European ADRs Move Lower in Friday Trading
MT
More news
Financials
Sales 2021 30,4 M 35,4 M 35,4 M
Net income 2021 -12,2 M -14,2 M -14,2 M
Net Debt 2021 - - -
P/E ratio 2021 -16,1x
Yield 2021 -
Capitalization 132 M 154 M 154 M
Capi. / Sales 2021 4,34x
Capi. / Sales 2022 3,35x
Nbr of Employees 159
Free-Float 46,4%
Chart BIOFRONTERA AG
Duration : Period :
Biofrontera AG Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BIOFRONTERA AG
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 1
Last Close Price 2,33 €
Average target price 6,80 €
Spread / Average Target 192%
EPS Revisions
Managers and Directors
Hermann Lübbert Chairman-Management Board & CEO
Ludwig Lutter Chief Financial Officer
Ulrich Granzer Chairman-Supervisory Board
Jürgen Christian Baumann Vice Chairman-Supervisory Board
Kevin D. Weber Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
BIOFRONTERA AG-21.48%154
CSL LIMITED4.59%100 906
WUXI BIOLOGICS (CAYMAN) INC.14.69%64 326
SAMSUNG BIOLOGICS CO.,LTD.5.08%48 850
ALEXION PHARMACEUTICALS, INC.0.00%40 336
BIOGEN INC.10.16%39 960